Clinical Trials Directory

Trials / Completed

CompletedNCT01406080

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging

Single-blinded, Multicenter, Randomized, Comparative Study of Efficacy and Safety of Adapalene Gel 0.3% Versus Tretinoin Emollient Cream 0.05% in the Treatment of Cutaneous Photoaging.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Galderma Brasil Ltda. · Industry
Sex
All
Age
35 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to: 1. Evaluate the efficacy of Adapalene gel 0.3% compared to Tretinoin Emollient cream 0.05%, reducing signs of cutaneous photoageing, measured trough photonumeric scale evaluation, investigator evaluation of global response to treatment and subject's evaluation of improvement. 2. Evaluate the safety and tolerability of Adapalene Gel 0.3%, compared to Tretinoin Emollient cream 0.05% during 24 weeks of treatment. The study has the clinical hypothesis that Adapalene Gel 0.3% is as effective as Tretinoin Emollient cream 0.05% in the treatment of cutaneous photoaging.

Conditions

Interventions

TypeNameDescription
DRUGAdapaleneApply approximately 1 gram of Differin 0.3% every night on the entire face, except near the eye region.
DRUGTretinoinApply approximately 1 gram of Tretinoin emollient cream 0.05% every night on the entire face, except near the eye region.

Timeline

Start date
2013-01-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2011-07-29
Last updated
2017-04-06

Locations

4 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01406080. Inclusion in this directory is not an endorsement.